Volume | 2,640,424 |
|
|||||
News | (1) | ||||||
Day High | 32.0599 | Low High |
|||||
Day Low | 30.93 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Dyne Therapeutics Inc | DYN | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
31.95 | 30.93 | 32.0599 | 31.25 | 31.53 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
21,702 | 2,640,424 | US$ 31.56 | US$ 83,336,967 | - | 6.40 - 35.98 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:54:57 | formt | 10,530 | US$ 31.25 | USD |
Dyne Therapeutics (DYN) Options Flow Summary
Dyne Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
2.57B | 81.96M | - | 0 | -235.94M | -2.88 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Dyne Therapeutics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DYN Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 27.23 | 35.98 | 27.04 | 32.28 | 3,199,405 | 4.02 | 14.76% |
1 Month | 24.90 | 35.98 | 23.16 | 29.75 | 1,366,579 | 6.35 | 25.50% |
3 Months | 25.66 | 35.98 | 23.11 | 27.81 | 1,407,079 | 5.59 | 21.78% |
6 Months | 10.53 | 35.98 | 10.12 | 21.86 | 1,623,375 | 20.72 | 196.77% |
1 Year | 13.91 | 35.98 | 6.40 | 18.88 | 1,071,528 | 17.34 | 124.66% |
3 Years | 18.08 | 35.98 | 4.30 | 16.84 | 529,342 | 13.17 | 72.84% |
5 Years | 23.45 | 35.98 | 4.30 | 17.15 | 493,199 | 7.80 | 33.26% |
Dyne Therapeutics Description
Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. |